Followers | 8 |
Posts | 1,704 |
Boards Moderated | 0 |
Alias Born | 10/17/2015 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Picked up another 50k. Let's go $.24 which is not a long shot!
Have you done ANY due diligence, the stapler is used in almost every life saving surgery. May not be the company anyone is really after, heck all they really need is the patient.
Nevertheless I will keep building a stronger position at these prices.
The $.80 pps placed here earlier and Zacks hold with the 1.67 brokers recommendation, makes $.20 - $.40 a worthwhile risk.
My belief is that the misses on the last two estimates will drive a super low estimate for 4th quarter, and pending a few moves DXTR is projected to make and assistance in production and shipping, they'll kill the estimate driving the pps well over $1 right before delisting, which then we will possibly see the RS to make the pps and merge/bo talks worth much more.
Final estimates if all this were to take place is a pps around $8 - $10. Right on target for a pharmaceutical supply company.
DD shows we are at the bottom, expect the pps to begin to hit people's buy targets
Any news on FDA approval
News coming by end of month!
Able to buy back at $.21 added another 25k
I expect a buyout at the minimum amount of $.45 - $.80
Late reporting, my guess is that the company is waiting and will release annual report with some very big news
Said it could, didn't say it should. Still sticking with the $.80 Zacks prediction.
Could go all the way to $2 today yesterday's action could have been a last ditch effort to accumulate.
Selling, creates buying, stop limits yesterday is what I expect was most likely the majority of sales/purchases created by market makers....this is why I buy
The tactic may be used more than once prior a major change in a companies forward looking statement to induce selling in order to purchase existing options and to reduce the costs of the company.
Calls and puts are also affected when this happens, rule of thumb is don't panic and time the buy at the right time, as you seen yesterday we are already almost back to the pps being at $.30
Premarket looking good, so glad I bought yesterday about $.22
Awesome bought another 25k, trying to free up some more power for this at these prices.
Nope won't bounce until it hits a solid bottom
This is becoming a typical penny stock, get ready for major losses.
Looking like that bottom was hit. With the new base of $.30 should be no time at all we move to $.50
Very low volume, if buyout expect initial offers around $.60, a week later $.80, then $1. Need to get to the $2 in order to maintain some reputation on the NASDAQ platform.
L2s are very thin going up, anticipation for a big move
$.80-$1.00 coming soon
Believe this will shoot back to $.004s before the New Year
90 days almost up FDA coming $.16 soon
Wow imagine that today's pps down! Thanks Clay :(
Going down to $0.04 again
Smells bad for new buyers maybe another lost lawsuit or maybe a reverse, nevertheless it's going to leave someone holding the bag, pps should be around $0.12 like 3 months ago.
Believe we see a string of news releases and $0.80!
Hmmm, guess I was right. Believe this will be new consolidation point for the months out through October, where we see a small rise November and beginning of December and the the floor drops out and goes to subpenny....only to see life again in late January with more financing...then dilution...then reverse to make stock appealing again (rinse and repeat)
Zacks showing two brokerages upgraded to strong buy
I'm thinking that we see another catalyst this week and the pps goes over $0.50
If the rose needs to be pinned on anyone, how about Clay and his cronies.
I'm no longer short and am going long but still believe that it has a pps of $.03 but will buy the dip
All of the selling today, MMs will use .315 as new base/launch pad and possibly see another run later this week.
$.80 price still looking achievable
Never really hear from you until pps starts to drrrrop (Beasty Boys)
MMs are bounded to maintain a certain volume, soon they too will have to start taking a loss here.
New manipulation begins, no catalyst why this is going up except for longs being stuck hard and MMs.
Very low volume, soon as real volume hits this goes subpenny
L2s very thin
With the authorized shares at 1,000,000,000 and the continuation of issuing warrants that are maturing, my guess is another 1:800-1000 reverse in the future. Keep lining the pockets, last quarter revenue was 21,000 from one person....not very compelling for investors and/or FDA.
So why?
Broker than broke.
Financing might pay for payroll, but believe little is going to actually getting the reworks needed for any chance with FDA.
Overseas sales are paying for overhead costs like production, packaging, shipping.
And god forbid if something goes wrong with the use, company couldn't even pay lawyer fees, let alone a settlement.
But you'll never hear about it, not many people reporting in third world countries, that is why I believe it has not passed any FDA trials in over 5 years.
$.03 all day if not subpenny!
I'm guessing that next week we get back the 15% consolidation the last few days, shorts can't keep up with the amount of new investors won this week, good things coming.
Buying